The obstructive laryngitis treatment global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Obstructive Laryngitis Treatment Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The obstructive laryngitis treatment market size has grown strongly in recent years. It will grow from $1.85 billion in 2023 to $1.95 billion in 2024 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to rising incidence of conditions such as vocal cord paralysis, increased demand for effective treatment options, rise in respiratory and laryngeal disorders, growth in telemedicine, and rising awareness and use of voice therapy.
The obstructive laryngitis treatment market size is expected to see strong growth in the next few years. It will grow to $2.44 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing the need for treatment options, growing incidences of bacterial and viral infections, growing aging population, rising exposure to harmful chemicals, and rising healthcare expenditure. Major trends in the forecast period include technological advancements, integration of telemedicine, biologic therapies, diagnostic imaging, and machine learning.
Order your report now for swift delivery @
Scope Of Obstructive Laryngitis Treatment Market
The Business Research Company’s reports encompass a wide range of information, including:
- Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
- Drivers: Examination of the key factors propelling market growth.
- Trends: Identification of emerging trends and patterns shaping the market landscape.
- Key Segments: Breakdown of the market into its primary segments and their respective performance.
- Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
- Macro Economic Factors: Assessment of broader economic elements impacting the market.
Obstructive Laryngitis Treatment Market Overview
Market Drivers –
The growing incidences of bacterial and viral infections are expected to propel the growth of the obstructive laryngitis treatment market going forward. Bacterial and viral infections are caused by microorganisms called bacteria and viruses, which invade the body, reproduce, and disturb normal bodily activities. The growing incidence of bacterial and viral infections can be attributed to several factors, including increased global travel, climate change, and antibiotic resistance. Obstructive laryngitis treatment involves antibiotics and corticosteroids to eliminate pathogens and reduce inflammation, while viral infections are managed with symptomatic treatments, corticosteroids for severe inflammation, and supportive care such as voice rest and hydration. For instance, in November 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, around 10.6 million cases of tuberculosis (TB) are predicted to occur globally in 2022, affecting 5.8 million men, 3.5 million women, and 1.3 million children. Therefore, the growing incidences of bacterial and viral infections are driving the obstructive laryngitis treatment market.
Market Trends –
Major companies operating in the obstructive laryngitis treatment market are focusing on developing innovative solutions, such as chewable tablets, to prevent acid from escaping into the esophagus, alleviating pain and discomfort. A chewable tablet is a solid dosage form of medication designed to be chewed before swallowing, allowing for easier ingestion and faster absorption. For instance, in June 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based manufacturing company, launched the anti-reflux antacid sodium alginate + potassium bicarbonate chewable tablet. The anti-reflux antacid chewable tablet containing sodium alginate and potassium bicarbonate, launched by Akums Drugs and Pharmaceuticals Ltd., is primarily used to treat acid reflux and gastroesophageal reflux disease (GERD). In the context of laryngitis treatment, it may help reduce larynx irritation caused by acid reflux, which can lead to or worsen laryngitis. By forming a protective barrier in the stomach, the tablet prevents acid from rising into the esophagus and throat, alleviating symptoms such as throat irritation and inflammation that can exacerbate laryngitis.
The obstructive laryngitis treatment market covered in this report is segmented –
1) By Medication: Glucocorticoid, Dexamethasone, Epinephrine
2) By Route Of Administration: Oral, Intravenous, Other Route Of Administration
3) By Drug Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
Get an inside scoop of the obstructive laryngitis treatment market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19621&type=smp
Regional Insights –
North America was the largest region in the obstructive laryngitis treatment market in 2023. The regions covered in the obstructive laryngitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the obstructive laryngitis treatment market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, Macleods Pharmaceuticals Limited, Aurobindo Pharma Limited, Cipla Limited, Cadila Healthcare Limited, Dr. Reddy’s Laboratories Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Mankind Pharma Limited, Unichem Laboratories Limited, Mylan N.V., Strides Pharma Science Limited, USV Private Limited
Table of Contents
- Executive Summary
- Obstructive Laryngitis Treatment Market Report Structure
- Obstructive Laryngitis Treatment Market Trends And Strategies
- Obstructive Laryngitis Treatment Market – Macro Economic Scenario
- Obstructive Laryngitis Treatment Market Size And Growth
…..
- Obstructive Laryngitis Treatment Market Competitor Landscape And Company Profiles
- Key Mergers And Acquisitions
- Future Outlook and Potential Analysis
- Appendix
Read Related Reports:
https://goodprnews.com/alternative-tourism-market-size/
https://topprnews.com/artificial-intelligence-ai-in-3d-printing-market-analysis/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
